title: Limitations of cholesterol lowering with PCSK9 inhibitors.
authors.affiliation: Metabolic Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK. Electronic address: g.thompson@imperial.ac.uk.
authors.forename: Gilbert
authors.initials: G
authors.lastname: Thompson
mesh_terms: D000911:Antibodies, Monoclonal; D000924:Anticholesteremic Agents; D002784:Cholesterol; D008078:Cholesterol, LDL; D006801:Humans; D000071449:Proprotein Convertase 9
chemical_list: D000911:Antibodies, Monoclonal; D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D002784:Cholesterol; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9